Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Page Path

HOME
ARTICLE CATEGORY
Review

Review

Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease

Karn Wijarnpreecha, Elizabeth S. Aby, Aijaz Ahmed, Donghee Kim

Clin Mol Hepatol. 2021;27(2):221-235. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0239

View: 8868 Download: 368 Web of Science: 27 Crossref: 33

The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future

Yusuke Watanabe, Atsunori Tsuchiya, Shuji Terai

Clin Mol Hepatol. 2021;27(1):70-80. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0194

View: 12713 Download: 408 Web of Science: 81 Crossref: 82

Recent updates on the management of autoimmune hepatitis

Atsumasa Komori

Clin Mol Hepatol. 2021;27(1):58-69. Published online December 10, 2020

DOI: https://doi.org/10.3350/cmh.2020.0189

View: 16133 Download: 1,220 Web of Science: 69 Crossref: 79

Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective

Gwyneth Soon, Aileen Wee

Clin Mol Hepatol. 2021;27(1):44-57. Published online November 19, 2020

DOI: https://doi.org/10.3350/cmh.2020.0181

View: 13365 Download: 370 Web of Science: 36 Crossref: 38

The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease

Erica Jennison, Christopher D. Byrne

Clin Mol Hepatol. 2021;27(1):22-43. Published online December 10, 2020

DOI: https://doi.org/10.3350/cmh.2020.0129

View: 10109 Download: 435 Web of Science: 51 Crossref: 55

Current understanding of primary biliary cholangitis

Atsushi Tanaka

Clin Mol Hepatol. 2021;27(1):1-21. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0028

View: 14892 Download: 867 Web of Science: 70 Crossref: 75

Precision medicine in nonalcoholic fatty liver disease: New therapeutic insights from genetics and systems biology

Silvia Sookoian, Carlos J. Pirola

Clin Mol Hepatol. 2020;26(4):461-475. Published online September 10, 2020

DOI: https://doi.org/10.3350/cmh.2020.0136

View: 9014 Download: 289 Web of Science: 40 Crossref: 40

Managing liver cirrhotic complications: Overview of esophageal and gastric varices

Cosmas Rinaldi Adithya Lesmana, Monica Raharjo, Rino A. Gani

Clin Mol Hepatol. 2020;26(4):444-460. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0022

View: 13478 Download: 707 Web of Science: 61 Crossref: 63

Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease

Kyung-Soo Kim, Byung-Wan Lee

Clin Mol Hepatol. 2020;26(4):430-443. Published online August 14, 2020

DOI: https://doi.org/10.3350/cmh.2020.0137

View: 10484 Download: 490 Web of Science: 40 Crossref: 44

Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop

Hyung Joon Yim, Ji Hoon Kim, Jun Yong Park, Eileen L. Yoon, Hana Park, Jung Hyun Kwon, Dong Hyun Sinn, Sae Hwan Lee, Jeong-Hoon Lee, Hyun Woong Lee

Clin Mol Hepatol. 2020;26(4):411-429. Published online August 28, 2020

DOI: https://doi.org/10.3350/cmh.2020.0049

View: 15410 Download: 1,456 Web of Science: 66 Crossref: 66

Liver graft from donation after circulatory death donor: Real practice to improve graft viability

Koji Hashimoto

Clin Mol Hepatol. 2020;26(4):401-410. Published online July 10, 2020

DOI: https://doi.org/10.3350/cmh.2020.0072

View: 6515 Download: 167 Web of Science: 9 Crossref: 10

Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH

Theresa J. Hydes, Sujan Ravi, Rohit Loomba, Meagan E. Gray

Clin Mol Hepatol. 2020;26(4):383-400. Published online July 17, 2020

DOI: https://doi.org/10.3350/cmh.2020.0067

View: 11054 Download: 525 Web of Science: 53 Crossref: 54

Fecal microbiota transplantation in alcohol related liver diseases

Saggere Muralikrishna Shasthry

Clin Mol Hepatol. 2020;26(3):294-301. Published online June 23, 2020

DOI: https://doi.org/10.3350/cmh.2020.0057

View: 7696 Download: 230 Web of Science: 24 Crossref: 26

Role of cytoglobin, a novel radical scavenger, in stellate cell activation and hepatic fibrosis

Le Thi Thanh Thuy, Hoang Hai, Norifumi Kawada

Clin Mol Hepatol. 2020;26(3):280-293. Published online June 4, 2020

DOI: https://doi.org/10.3350/cmh.2020.0037

View: 8123 Download: 238 Web of Science: 14 Crossref: 15

Novel biomarkers for the management of chronic hepatitis B

Takako Inoue, Yasuhito Tanaka

Clin Mol Hepatol. 2020;26(3):261-279. Published online June 15, 2020

DOI: https://doi.org/10.3350/cmh.2020.0032

View: 15757 Download: 710 Web of Science: 80 Crossref: 83

Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy

Chung-Feng Huang, Ming-Lung Yu

Clin Mol Hepatol. 2020;26(3):251-260. Published online March 19, 2020

DOI: https://doi.org/10.3350/cmh.2020.0018

View: 14946 Download: 392 Web of Science: 41 Crossref: 43

Switching to systemic therapy after locoregional treatment failure: Definition and best timing

Sadahisa Ogasawara, Yoshihiko Ooka, Keisuke Koroki, Susumu Maruta, Hiroaki Kanzaki, Kengo Kanayama, Kazufumi Kobayashi, Soichiro Kiyono, Masato Nakamura, Naoya Kanogawa, Tomoko Saito, Takayuki Kondo, Eiichiro Suzuki, Shingo Nakamoto, Akinobu Tawada, Tetsuhiro Chiba, Makoto Arai, Jun Kato, Naoya Kato

Clin Mol Hepatol. 2020;26(2):155-162. Published online January 15, 2020

DOI: https://doi.org/10.3350/cmh.2019.0021n

View: 10514 Download: 418 Web of Science: 45 Crossref: 41

Drug induced liver injury: East versus West – a systematic review and meta-analysis

En Xian Sarah Low, Qishi Zheng, Edwin Chan, Seng Gee Lim

Clin Mol Hepatol. 2020;26(2):142-154. Published online December 10, 2019

DOI: https://doi.org/10.3350/cmh.2019.1003

View: 9862 Download: 547 Web of Science: 25 Crossref: 27

Application of transient elastography in nonalcoholic fatty liver disease

Xinrong Zhang, Grace Lai-Hung Wong, Vincent Wai-Sun Wong

Clin Mol Hepatol. 2020;26(2):128-141. Published online November 8, 2019

DOI: https://doi.org/10.3350/cmh.2019.0001n

View: 15243 Download: 570 Web of Science: 67 Crossref: 72

Regulated differentiation of stem cells into an artificial 3D liver as a transplantable source

Feng Chen, Hua Wang, Jia Xiao

Clin Mol Hepatol. 2020;26(2):163-179. Published online February 27, 2020

DOI: https://doi.org/10.3350/cmh.2019.0022n

View: 10206 Download: 274 Web of Science: 4 Crossref: 3

Extrahepatic manifestations of hepatitis E virus: An overview

Fotios S. Fousekis, Ioannis V. Mitselos, Dimitrios K. Christodoulou

Clin Mol Hepatol. 2020;26(1):16-23. Published online October 11, 2019

DOI: https://doi.org/10.3350/cmh.2019.0082

View: 10093 Download: 394 Web of Science: 41 Crossref: 40

The fibrogenic process and the unleashing of acute-on-chronic liver failure

Guillermo Nahúm López-Sánchez, Mayra Dóminguez-Pérez, Misael Uribe, Natalia Nuño-Lámbarri

Clin Mol Hepatol. 2020;26(1):7-15. Published online June 14, 2019

DOI: https://doi.org/10.3350/cmh.2019.0011

View: 12078 Download: 370 Web of Science: 10 Crossref: 11

Immunologic strategies and outcomes in ABO-incompatible living donor liver transplantation

Jongwook Oh, Jong Man Kim

Clin Mol Hepatol. 2020;26(1):1-6. Published online March 26, 2019

DOI: https://doi.org/10.3350/cmh.2019.0023

View: 16222 Download: 621 Web of Science: 26 Crossref: 26

Upcoming direct acting antivirals for hepatitis C patients with a prior treatment failure

Tommaso Lorenzo Parigi, Maria Corina Plaz Torres, Alessio Aghemo

Clin Mol Hepatol. 2019;25(4):360-365. Published online May 2, 2019

DOI: https://doi.org/10.3350/cmh.2019.0022

View: 5891 Download: 245 Web of Science: 9 Crossref: 10

Appropriate treatment modality for solitary small hepatocellular carcinoma: Radiofrequency ablation vs. resection vs. transplantation?

Keun Soo Ahn, Koo Jeong Kang

Clin Mol Hepatol. 2019;25(4):354-359. Published online April 22, 2019

DOI: https://doi.org/10.3350/cmh.2018.0096

View: 8143 Download: 366 Web of Science: 46 Crossref: 44

Ultraselective conventional transarterial chemoembolization: When and how?

Shiro Miyayama

Clin Mol Hepatol. 2019;25(4):344-353. Published online April 26, 2019

DOI: https://doi.org/10.3350/cmh.2019.0016

View: 11711 Download: 566 Web of Science: 30 Crossref: 33

Detect or not to detect very early stage hepatocellular carcinoma? The western perspective

Ju Dong Yang

Clin Mol Hepatol. 2019;25(4):335-343. Published online March 29, 2019

DOI: https://doi.org/10.3350/cmh.2019.0010

View: 11380 Download: 249 Web of Science: 42 Crossref: 42

Sarcopenia: Ammonia metabolism and hepatic encephalopathy

Ankur Jindal, Rakesh Kumar Jagdish

Clin Mol Hepatol. 2019;25(3):270-279. Published online April 22, 2019

DOI: https://doi.org/10.3350/cmh.2019.0015

View: 17269 Download: 940 Web of Science: 68 Crossref: 74

Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?

Ibrahim A. Hanouneh, Naim Alkhouri, Amit G. Singal

Clin Mol Hepatol. 2019;25(3):264-269. Published online March 4, 2019

DOI: https://doi.org/10.3350/cmh.2019.1001

View: 10340 Download: 333 Web of Science: 49 Crossref: 50

Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update

Tae-Hyung Kim, So Yeon Kim, An Tang, Jeong Min Lee

Clin Mol Hepatol. 2019;25(3):245-263. Published online February 14, 2019

DOI: https://doi.org/10.3350/cmh.2018.0090

View: 19614 Download: 1,050 Web of Science: 144 Crossref: 154

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Impact Factor

14.0
First decision

07 Days

Publication after acceptance

03 Days

*Last 12 months

Viewed By 5155	MAFLD: How is it different from NAFLD?
Viewed By 4900	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4874	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 4583	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4568	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 219	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 155	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 134	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 119	MAFLD: How is it different from NAFLD?
Cited By 96	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach